Silexion Therapeutics SLXN
NASDAQ SLXN
$0.27 -0.05 (-15.55%)
As of: Sep 30, 2026 · 3:23 PM EDT

Silexion Therapeutics (SLXN) Total Debt (2024 - 2025)

Updated

Silexion Therapeutics' Total Debt came in at $1.57 million for Q4 2025, down 47.0% from $2.96 million a year earlier but up 1.8% from the prior quarter.

Analysis

Silexion Therapeutics (SLXN) Total Debt (2024 - 2025) Analysis & Trends

Going back to Q3 2024, Silexion Therapeutics' Total Debt data covers 6 quarters.

  • Going back by year, Total Debt was $2.96 million in FY2024.
  • The five-year range for quarterly Total Debt is $1.54 million (Q3 2025) to $3.19 million (Q2 2025).
  • Business Quant data shows SLXN's Total Debt at $1.54 million (Q3 2025), $3.19 million (Q2 2025) and $2.99 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 49.04 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 70.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -111.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Silexion Therapeutics 219,952.96 -19.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.57 Mn
Sep 30, 2025 1.54 Mn
Jun 30, 2025 3.19 Mn
Mar 31, 2025 2.99 Mn
Dec 31, 2024 2.96 Mn
Sep 30, 2024 3.11 Mn
API Access

Silexion Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=SLXN&period=max&api_key=YOUR_API_KEY